Generally good place to work, but continuously downsizing since 2003 - forget about work-life balance. - Recensione dipendente - Manager presso Merck

4,0
28 lug 2012
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

- Good place to get solid experience in manufacturing environment, great place for recent grads to work. - Highly ethical in practices and policies. Driving to consistency across the board in policies and procedures - Promote employee speaking up (courage and candor) - Compensation, though reduced, is within market ranges

Svantaggi

- Very elitist and level conscious leaders. Recent compensation restructuring was oriented toward keeping executives and high level officials well-paid, all other professionals were stuffed in general buckets, reducing salary ranges, performance bonuses and long term incentives (non existent below management level). - Continuous downsizing since about 2003, each year depts must provide headcount reductions with significant increases in workload (no workload analysis allowed). The workload has become ridiculous - absolutely no work-life balance.

Esplora altre recensioni su Merck

5,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Excellent company to work with.

Svantaggi

No cons encountered so far

4,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Svantaggi

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Vedi recensioni per: Utile|Valutazione|Data|Tutto